PAR paradigm biopharmaceuticals limited..

Where are we on a deal?, page-8

  1. 598 Posts.
    lightbulb Created with Sketch. 150
    I re-listened to sharewise interview. Paul states the companies biggest risk, once the IND phase 3 acceptance goes through is……….. not financial ruin/risk, but execution risk.

    A partner is signed in non binding….. surely. We sit and wait
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
28.3¢
Change
-0.008(2.59%)
Mkt cap ! $109.0M
Open High Low Value Volume
29.0¢ 29.0¢ 28.0¢ $24.30K 85.28K

Buyers (Bids)

No. Vol. Price($)
18 285226 28.0¢
 

Sellers (Offers)

Price($) Vol. No.
29.0¢ 62707 4
View Market Depth
Last trade - 13.56pm 17/06/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.